Rthp-10. phase ii study of hypo vs. conventional -fractionated radiotherapy with temozolomide in newly diagnosed glioblastoma: early compliance and tolerance
CONCLUSION:Hypofractionated radiation appears to be well tolerated with no treatment interruption. However, longer follow up of the study will be able to conclude the possibility of incorporating hypo fractionation in regular treatment of newly diagnosed GBM.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Mallick, S., parambath Haresh, K. Tags: RADIATION THERAPY Source Type: research
More News: Cancer & Oncology | Hematology | Neurology | Radiation Therapy | Study | Temodar | Toxicology